Women with Postpartum Depression

research study because you have been diagnosed as suffering from postpartum depression and are a woman between the ages of 18 and 48 years old.

» Study Details | Apply for the Study

Treatment for Acne Vulgaris

Acne is the most common skin disease in the US and affects 80% of the population at some point in life.

» Study Details | Apply for the Study

PATIENTS WITH TYPE 2 DIABETES MELLITUS

STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SUBCUTANEOUS BFKB8488A IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

» Study Details | Apply for the Study

Upcoming Studies for Men & Women

» Study Details | Apply for the Study

Asthma

Inadequately Controlled Asthma

» Study Details | Apply for the Study

COPD

Qualified Subjects:

Male or female COPD subjects; Age ≥ 40  and ≤ 85
History of 2 or more moderate COPD exacerbation(s) that required within the last year
more....

» Study Details | Apply for the Study

Endometrial Hyperplasia

Estradiol to Reduce the Frequency and Severity of Vasomotor Symptoms and Progesterone to Manage the Incidence of Endometrial Hyperplasia

» Study Details | Apply for the Study

Hot flushes and sweating on menopause woman

A decrease in estrogen at the time of menopause is associated with vasomotor instability (hot flushes and sweating), agitation, sleep disturbances, nervousness, mood changes, and urogenital atrophy.

» Study Details | Apply for the Study

Type 2 Diabetes Mellitus (T2DM), and Nonalcoholic Fatty Liver Disease (NAFL

Patients with Hypertriglyceridemia, Type 2 Diabetes Mellitus (T2DM), and Nonalcoholic Fatty Liver Disease (NAFLD)

» Study Details | Apply for the Study

Crohn's Disease

Observational Study on Crohn's for Free.
If you are:
  Males and females 18 to 55 years of age.
  Signed fully informed consent provided as per this protocol.
  Diagnosis of Crohn's Disease confirmed by endoscopy or radiography and/or histology at least 6 months prior to randomization into the study.

Contact us NOW to be eligible for a observational study and receive free medication and upto $50 per visit for your time compensation.
Other exclusion criteria apply.

» Study Details | Apply for the Study

MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS WHO ARE REFRACTORY TO OR INTOL

THE EFFICACY AND SAFETY OF ETROLIZUMAB DURING INDUCTION AND MAINTENANCE IN PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS WHO ARE REFRACTORY TO OR INTOLERANT OF TNF INHIBITORS

» Study Details | Apply for the Study

Chronic Idiopathic Constipation

Constipation is one of the most frequent gastrointestinal complaints worldwide. In the United States it is one of the common reasons for a visit to the physician.

» Study Details | Apply for the Study

Irritable Bowel Syndrome Experiencing Abdominal Pain

The CAPTIVATE Study is a clinical study to evaluate how an investigational study medication called olorinab may reduce abdominal pain in people with IBS. You are being asked to see if you qualify in this study. The investigational study medication has been previously tested in healthy volunteers and in a small group of people with Crohn’s disease experiencing abdominal pain. The investigational study treatment in the CAPTIVATE Study is taken orally 3 times a day. This study is designed to evaluate whether olorinab can reduce abdominal pain associated with IBS.

You may be eligible to participate in this study if you: are

18-70 years of age have been diagnosed with IBS with constipation or diarrhea (IBS-C or IBS-D) experience abdominal pain due to IBS  

Other eligibility criteria apply.

Eligible participants will receive study-related health assessments and study-related treatment (olorinab or placebo) at no cost. You'll be paid for each completed visit. Enrollment is currently open for this study.

» Study Details | Apply for the Study

Celiac Disease on a Gluten Free Diet

If you are experiencing celiac disease symptoms despite following a gluten-free diet, you may want to talk to your doctor about our clinical study.

» Study Details | Apply for the Study

Ulcerative Colitis Study

A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy and Safety of Brazikumab in Participants with Moderately to Severely Active Ulcerative Colitis

» Study Details | Apply for the Study

Moderately to Severely Active Crohn’s Disease

A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-Controlled, Operationally Seamless Phase 2b/3, Parallel-group Study to Assess the Efficacy and Safety of Brazikumab in Participants with Moderately to Severely Active Crohn’s Disease

» Study Details | Apply for the Study

Type 2 Diabetes, Inadequately Controlled with Diet and Exercise Alone

A study looking for subjects who were diagnosed with  Type 2 Diabetes, Inadequately Controlled with Diet and Exercise Alone

» Study Details | Apply for the Study

Type 2 Diabetes Mellitus and Diabetic Nephropathy

Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy

» Study Details | Apply for the Study

Chronic Migraine

Evaluate the Efficacy, Safety of Pharmacokinetics Administered Intravenously in Patients with Chronic Migraine

» Study Details | Apply for the Study

Multiple Sclerosis

Patients with relapsing forms of multiple sclerosis who are being treated with an approved disease-modifying therapies (DMT).

» Study Details | Apply for the Study

Memory Loss

FEEL YOUR MEMORY ISN’T WHAT IT USED TO BE?

Many people find their memory changes as hey get older. You might forget people’s names or have words on the tip of your tongue that you can’t quite remember. You might feel a little absentminded, such as misplacing your keys or glasses or forgetting why you walked into a room. For most people, these changes are a normal nd natural part of aging.
But in some cases, these changes are signs of something more serious — Alzheimer’s disease.
Alzheimer’s disease is a progressive brain disease (meaning that it gets worse over time). It affects the way a person thinks, reasons, and solves problems. Over time, Alzheimer’s disease can
also affect behavior, personality, and language.
While there is no cure for Alzheimer’s disease, doctors are researching investigational drugs to see if they may help people with Alzheimer’s disease in the future.

» Study Details | Apply for the Study

Moderate to Severe Endometriosis-Associated Pain

Endometriosis is a chronic oestrogen-dependent condition characterised by the growth of endometrial tissue in sites other than the uterine cavity, most commonly the pelvic cavity (including the ovaries), the uterosacral ligaments, the pouch of Douglas, the rectosigmoid colon, and the bladder and distal ureter

» Study Details | Apply for the Study

Contraceptive Gel Study

A PHASE III, MULTICENTER, OPEN-LABEL, RANDOMIZED, CONTROLLED STUDY OF THE CONTRACEPTIVE EFFICACY AND SAFETY OF AMPHORA® VAGINAL GEL COMPARED WITH CONCEPTROL® VAGINAL GEL

» Study Details | Apply for the Study

Vilaprisan in subjects with uterine fibroids

Vilaprisan in subjects with uterine fibroids versus standard of care

» Study Details | Apply for the Study

Vaginal Rejuvenation

This Study is indicated for treatment of women with diminished sexual function following vaginal childbirth for the improvement of sexual function.

» Study Details | Apply for the Study

heavy menstrual bleeding associated with uterine fibroids in premenopausal

Heavy Menstrual Bleeding Associated with Uterine Fibroids

» Study Details | Apply for the Study

Vaginal Rejuvenation Study

Vaginal Rejuvenation Study using Viveve Geneveve Treatment of the vaginal Introitus. 

» Study Details | Apply for the Study

Hot Flashes Associated with Menopause

FEMALE SUBJECTS WITH MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH THE MENOPAUSE

» Study Details | Apply for the Study

Hot Flashes Associated with Menopause

Moderate to Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause

» Study Details | Apply for the Study

Women with Endometriosis Experiencing Endometrial Related Pain

The INANNA study is evaluating an investigational medication in women with moderate or severe endometriosis pain. You may qualify to participate if you: •• Are between 18 and 49 years of age •• Have been diagnosed with endometriosis within the last 5 years •• Have a 21-38 day menstrual cycle •• Are not pregnant, nursing or planning a pregnancy within the next 12 months •• Are willing to stop taking current hormonal endometriosis therapies (use of nonhormonal contraception methods is required during the study) Other criteria will be reviewed to determine if you qualify for this study.

» Study Details | Apply for the Study